Wolverine Trading, LLC Vir Biotechnology, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $733,174 - $1.38 Million	-34,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $331,379 - $578,121	10,700 Added 44.77%	34,600 $1.41 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $544,440 - $850,824	15,600 Added 187.95%	23,900 $1.03 Million
Q2 2021 Aug 06, 2021	SELL	$38.75 - $51.0 $275,125 - $362,100	-7,100 Reduced 46.1%	8,300 $386,000
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $405,636 - $1.28 Million	15,400 New	15,400 $736,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.